Reversed-Phase LC-MS Analysis of Low- Abundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column
Predictable Isolation of Radioligand Therapy Precursor PSMA-617 and Closely Eluting Impurities from a Forced Degradation Study Using a MaxPeak™ Premier OBD™ Preparative Column